# | Title | Journal | Year | Citations |
---|
1 | Practical Experience of Using Riamilovir in Treatment of Patients with Moderate COVID-19 | Antibiotiki I Khimioterapiya | 2020 | 14 |
2 | Associated resistance of Escherichia coli isolated from humans and animals to polymyxin and beta-lactam antibiotics | Antibiotiki I Khimioterapiya | 2022 | 11 |
3 | Clinical Efficiency and Safety of Riamilovir for Treating Patients with SARS-CoV-2 Infection | Antibiotiki I Khimioterapiya | 2021 | 10 |
4 | Multicentre Study of the Prevalence and Clinical Value of Hospital-Acquired Infections in Emergency Hospitals of Russia: ERGINI Study Team | Antibiotiki I Khimioterapiya | 2016 | 9 |
5 | Infections Caused by Carbapenem-Resistant Enterobacterales: Epidemiology, Clinical Significance, and Possibilities for Antibiotic Therapy Optimization | Antibiotiki I Khimioterapiya | 2020 | 8 |
6 | Antiviral Activity of Kagocel<sup>®</sup> in vitro Against Virus SARS-CoV-2 | Antibiotiki I Khimioterapiya | 2020 | 7 |
7 | Appointment of Antimicrobial Medications in a Hospital Depending on the Results of Microbiological Monitoring of HAI | Antibiotiki I Khimioterapiya | 2020 | 7 |
8 | The Efficacy and Safety of Riamilovir in the Treatment of Patients with COVID-19 | Antibiotiki I Khimioterapiya | 2021 | 6 |
9 | The Effectiveness of Antifungal Agents Against Yeasts of Candida Genus Isolated in Moscow Region | Antibiotiki I Khimioterapiya | 2020 | 6 |
10 | Antioxidants as Potential Antiviral Agents for Flavivirus Infections | Antibiotiki I Khimioterapiya | 2016 | 6 |
11 | Investigation of Thionins from Black Cumin (Nigella sativa L.) Seeds Showing Cytotoxic, Regulatory and Antifungal Activity | Antibiotiki I Khimioterapiya | 2016 | 6 |
12 | Meta-analysis of randomized controlled clinical trials of Riamilovir efficacy in the etiotropic therapy of acute respiratory viral infection | Antibiotiki I Khimioterapiya | 2021 | 5 |
13 | Prevalence and Antibiotic Resistance of Carbapenemase-Producing Gram-Negative Bacteria in Saint Petersburg and Some Other Regions of the Russian Federation | Antibiotiki I Khimioterapiya | 2016 | 5 |
14 | Antibacterial Therapy of Patients With COVID-19 During The Outpatient and Hospital Stages | Antibiotiki I Khimioterapiya | 2022 | 5 |
15 | An Open-Label, Multicenter, Observational Study of The Effectiveness of The Cefepime/Sulbactam Antibiotic (Maxictam<sup>®</sup>-AF) In Patients With Intra Abdominal Infection, Nosocomial Pneumonia or Ventilator-Associated Pneumonia (Study MAXI-2019) | Antibiotiki I Khimioterapiya | 2021 | 4 |
16 | Community-Acquired Pneumonia of Bacterial Etiology and the Spectrum of Pathogen Sensitivity to Antibiotics in Corona-Positive and Corona-Negative Patients in Rostov-on-Don | Antibiotiki I Khimioterapiya | 2021 | 4 |
17 | Cefepime/Sulbactam — A New Innovative Antibiotic for In-Hospital Treatment of Severe Infections and the Implementation of Carbapenem-Replacement Strategy to Contain Antibiotic Resistance | Antibiotiki I Khimioterapiya | 2021 | 4 |
18 | Study of Cases of Bacteremia with Gram-Negative Pathogens with Multiple and Extreme Antibiotic Resistance in Real Clinical Practice | Antibiotiki I Khimioterapiya | 2021 | 4 |
19 | Possibilities of suppressing the cytopathogenic effect of SARS-CoV-2 coronavirus according to the results of the antiviral activity of Cytovir®-3 <i>in vitro</i> study | Antibiotiki I Khimioterapiya | 2021 | 4 |
20 | Serotype composition of Streptococcus pneumoniae in children with respiratory infections, optimization of molecular assessment methods | Antibiotiki I Khimioterapiya | 2022 | 4 |
21 | Comparative Activity of Carbapenem Antibiotics Against Gram-Negative Carbapenemase Producers of Different Groups | Antibiotiki I Khimioterapiya | 2022 | 4 |
22 | Eradication, Strain Preservation, Strain Change — Outcomes of Helicobacter pylori Therapy | Antibiotiki I Khimioterapiya | 2021 | 3 |
23 | Comparative Effectiveness of Riamilovir and Umifenovir for Treating Influenza | Antibiotiki I Khimioterapiya | 2021 | 3 |
24 | The Corrective Effect of Fucoidan, a Sulfated Polysaccharide Extracted from Brown Algae Fucus evanescens, in the Formation of a Specific Immune Response Against Seasonal Influenza Viruses in the Elderly | Antibiotiki I Khimioterapiya | 2020 | 3 |
25 | Antibiotic-Resistant Uropathogenic Escherichia coli Isolated from Children with Congenital Abnormalities of the Kidneys and Urinary Tract | Antibiotiki I Khimioterapiya | 2020 | 3 |
26 | Seaweed-Derived Sulfated Polysaccharides as Potential Agents for Prevention and Treatment of Influenza and COVID-19 | Antibiotiki I Khimioterapiya | 2021 | 3 |
27 | Immunogenicity, Safety, and Clinical Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine in Patients With Spondyloarthritis (Preliminary Data) | Antibiotiki I Khimioterapiya | 2022 | 3 |
28 | Cytokine Storm in the Novel Coronavirus Infection and Methods of its Correction | Antibiotiki I Khimioterapiya | 2021 | 2 |
29 | Features of Preoperative Preparation of Patients with Burns and Chronic Ulcers of Various Etiology for Autodermoplasty | Antibiotiki I Khimioterapiya | 2021 | 2 |
30 | Pharmacokinetics of Pentanedioic Acid Imidazolyl Ethanamide in Healthy Volunteers | Antibiotiki I Khimioterapiya | 2021 | 2 |
31 | Analysis of Antibiotic Resistance of Vibrio Сholerae Isolated From Environmental Objects in Russia in 2019 | Antibiotiki I Khimioterapiya | 2021 | 2 |
32 | Possibilities of Hyperinflammation Correction in COVID-19 | Antibiotiki I Khimioterapiya | 2021 | 2 |
33 | Rationale for a New Outpatient Drug Therapy Algorithm in COVID-19 Patients Based on the Principle of «Multi-hit» Approach | Antibiotiki I Khimioterapiya | 2021 | 2 |
34 | Meta-analysis of randomized clinical trials of Riamilovir efficacy in etiotropic therapy of influenza | Antibiotiki I Khimioterapiya | 2021 | 2 |
35 | Determination of the Effectiveness of Antibiotic Therapy by Conducting Therapeutic Drug Monitoring | Antibiotiki I Khimioterapiya | 2020 | 2 |
36 | Microbial Biofilms: Modern Concepts | Antibiotiki I Khimioterapiya | 2020 | 2 |
37 | The Efficacy of a Peptide Product from the Pituitary Gland of <i>Rangifer tarandus</i> as an Antioxidant Agent Under the Combined Effects of Light Desynchronosis and Depriming Toxicant | Antibiotiki I Khimioterapiya | 2021 | 2 |
38 | Antiviral Activity of Kagocel® on the Model of Experimental Lethal Influenza Infection | Antibiotiki I Khimioterapiya | 2020 | 2 |
39 | The Influence of Polysaccharides from Sea Algae on the Pathogenetic Targets of <i>Helicobacter Pylori</i> — a New Direction in Therapy and Prevention of Infection | Antibiotiki I Khimioterapiya | 2020 | 2 |
40 | Meta-analytical evaluation of the clinical efficacy of a complex metabolic neuroprotector in patients with chronic cerebral ischemia | Antibiotiki I Khimioterapiya | 2022 | 2 |
41 | Fluorescence Polarization Immunoassay, for Express Control of Antibiotic Levels: Design and Characteristics for Chloramphenicol, as an Example | Antibiotiki I Khimioterapiya | 2016 | 2 |
42 | Evaluating Changes in The Clinical Presentation of Acute Obstructive Bronchitis in Preschool Children Using Antiviral Therapy | Antibiotiki I Khimioterapiya | 2016 | 2 |
43 | Methods and Approaches for Antibiotics Deteсtion | Antibiotiki I Khimioterapiya | 2022 | 2 |
44 | Mobile Genetic Elements of Prokaryotes and Their Role in the Formation of Antibiotic Resistance in Pathogenic Bacteria | Antibiotiki I Khimioterapiya | 2022 | 2 |
45 | The Effect of Rifampicin on the Induction of MDR1/P-gp Activity in Proinflammatory Human Macrophages | Antibiotiki I Khimioterapiya | 2022 | 2 |
46 | Study of the Antiviral Activity of Adamantane-Containing Chemical Compounds | Antibiotiki I Khimioterapiya | 2022 | 2 |
47 | Modern View on Enterococcus faecalis and Enterococcus faecium Resistance Mechanisms to Antibiotics | Antibiotiki I Khimioterapiya | 2021 | 1 |
48 | Survival Outcomes in Patients after Radical Surgery for Non-Small Lung Cancer: an 8-year Study at N. N. Blokhin Cancer Research Center | Antibiotiki I Khimioterapiya | 2021 | 1 |
49 | Baricitinib in the Treatment of Patients with COVID-19: A Review of International Data and Analysis of Clinical Results in the Russian Population | Antibiotiki I Khimioterapiya | 2021 | 1 |
50 | Cytokine tatus in patients with recurrent herpes infection | Antibiotiki I Khimioterapiya | 2021 | 1 |